Journal of Diabetes and Its Complications
Volume 23, Issue 2 , Pages 95-101 , March 2009

Incidence and risk factors of hypertension among Saudi type 2 diabetes adult patients: an 11-year prospective randomized study

Received 10 May 2007 ,Revised 25 September 2007 ,Accepted 23 October 2007.

References 

  1. Al-Nuaim AR, Al-Rubean K, Al-Mazrou Y, et al. Prevalence of diabetes mellitus, obesity and hypercholesterolemia in Saudi Arabia: National Chronic Disease Survey. Riyadh: Ministry of Health and King Saud University; 1995;
  2. American Diabetes Association . Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2004;27(suppl):S15–S35
  3. Borde-Perry W, Campbell K, Murtaugh K, et al. The association between hypertension and other cardiovascular risk factors in young adult African Americans. Journal of Clinical Hypertension. 2002;4:17–22
  4. Clarke P, Gray A, Briggs A, et al. Implementing more intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: Cost analysis (UKPDS 63). British Medical Journal. 2002;325:860–865
  5. Ekoé JM, Zimmet P, Williams R. The epidemiology of diabetes mellitus. An International Perspective. Chichester: Wiley; 2001;
  6. El-Hazmi MAF, Warsy AJ. Association of hypertension and non-insulin-dependent diabetes mellitus in the Saudi population. Annals of Saudi Medicine. 2001;21:5–8
  7. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal of Medicine. 2003;348:383–393
  8. Haffner SM, Valdez R, Morales PA, et al. Greater effect of glycemia on incidence of hypertension in women than in men. Diabetes Care. 1992;15:1277–1284
  9. Halimi JM, Giraudeau B, Vol S, et al. The risk of hypertension in men: Direct and indirect effects of chronic smoking. Journal of Hypertension. 2002;20:187–193
  10. Harris SB, Ekoé JM, Zdanowicz Y, et al. Glycemic control and morbidity in the Canadian primary care setting (Results of the Diabetes in Canada Evaluation Study). Diabetes Research and Clinical Practice. 2005;70:90–97
  11. International Diabetes Federation . Diabetes Atlas. 2nd ed.. International Diabetes Federation; 2003;Available at http://www.idf.org
  12. Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Diabetes Research and Clinical Practice. 2005;70:71–80
  13. Janghorbani M, Jones RB, Murray KJ, et al. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic Epidemiology. 2001;8:309–325
  14. JNC-VII (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure ( JNC VII). Journal of the American Medical Association. 2003;289:2560–2571
  15. Larijani B, Zahedi F, Aghakhani Sh. Epidemiology of diabetes mellitus in Iran. Shiraz E-Medical Journal. 2003;4:[Online]. Available from the Website: http://pearl.sums.ac.ir/semj/vol4/oct2003/DMinIran.htmAccessed on 3 Nov 2005
  16. Khan CR, Weir GC, King GL. Joslin's diabetes mellitus. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2005;
  17. Klein BE, Klein R, Moss SE, et al. A cohort study of the relationship of diabetic retinopathy to blood pressure. Archives of Ophthalmology. 1995;113:601–606
  18. Klein R, Klein BEK, Lee KE, et al. The incidence of hypertension in insulin-dependent diabetes. Archives of Internal Medicine. 1996;156:622–627
  19. Osman AK, Al-Nozha MM. Risk factors of coronary artery disease in different regions of Saudi Arabia. Eastern Mediterranean Health Journal. 2000;2-3:465–474
  20. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension. 2001;37:1053–1059
  21. The Hypertension in Diabetes Study Group . Hypertension in Diabetes Study (HDS I): Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. Journal of Hypertension. 1993;11:309–317
  22. UK Prospective Diabetes Study Group . Overview of six years' therapy of type 2 diabetes—a progressive disease (UKPDS 16). Diabetes. 1995;44:1249–1258
  23. Uusitupa MI, Niskanen LK, Siitonen O, et al. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993;36:1175–1184
  24. Wahid AA, Al Shammary FJ, Khoja TA, et al. Prevalence of hypertension and sociodemographic characteristics of adult hypertensives in Riyadh City, Saudi Arabia. Journal of Human Hypertension. 1996;10:583–587
  25. Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Annals of Internal Medicine. 2002;136:493–503
  26. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: Report of the Fourth Working Party of the British Hypertension Society. Journal of Human Hypertension. 2004;18:139–185
  27. World Health Organization (WHO) . World Health Report. Geneva: World Health Organization; 1997;

PII: S1056-8727(07)00132-8

doi: 10.1016/j.jdiacomp.2007.10.004

Journal of Diabetes and Its Complications
Volume 23, Issue 2 , Pages 95-101 , March 2009

Article Tools